Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

I’m 57 with a $1.5M home and a $400K rental with a 7.4% mortgage. I’m getting a $375K check soon. My financial adviser told ...

This was the stock's second consecutive day of losses.

The company is willing to back new limits on lucrative payments insurers can gain from diagnoses recorded by nurse ...

Humana backs move to limit extra payments from home-visit diagnoses - report ...

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

Due to the sharp price decline, the yield from the stock's dividend has climbed to 2.8%, which is higher than the S&P 500 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our ...